Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, not recruiting

SP Thoracic IDE Study

NCT05150210

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Benign Lung Disease, +19 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, not recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

NCT04680052

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • John Muir Health Clinical Research Center Concord, California, United States
  • Marin Cancer Care Greenbrae, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 261 locations
View Trial Details
Active, not recruiting

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

NCT03330691

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Active, not recruiting

Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia

NCT03620903

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Studiengesellschaft Onkologie Bielefeld GbR Bielefeld, Germany
  • DIAKO Ev. Diakonie-Krankenhaus gGmbH, Med. Klinik II Bremen, Germany
  • Universitätsklinikum Halle, Klinik für Innere Medizin IV Halle, Germany
  • Universtätsmedizin Mannheim, III. Medizinische Klinik Studienzentrale im MCC Mannheim, Germany
View Trial Details

Related conditions